Understanding the neurotoxicity effects of CAR-T cell therapy
Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy
This study is looking at the brain-related side effects that some people might experience after receiving CAR-T cell therapy, especially a condition called ICANS, to better understand how it affects thinking and memory over time, so we can help patients feel better and manage their care more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10945877 on NIH RePORTER |
What this research studies
This research investigates the neurological side effects associated with CAR-T cell therapy, particularly focusing on a condition known as immune effector cell-associated neurotoxicity syndrome (ICANS). The study aims to characterize both acute and chronic neurological symptoms that may arise in patients receiving this treatment. By analyzing blood markers and conducting neurocognitive assessments, researchers hope to uncover the underlying mechanisms of these toxicities and their long-term impacts on patients' cognitive functions. This work is crucial for improving patient management and outcomes following CAR-T therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are receiving CAR-T cell therapy for hematologic malignancies.
Not a fit: Patients who are not undergoing CAR-T cell therapy or those with pre-existing severe neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of neurotoxicity in patients undergoing CAR-T cell therapy, potentially improving their quality of life.
How similar studies have performed: While CAR-T therapy has shown remarkable efficacy in treating certain cancers, the specific investigation of neurotoxicity and its chronic effects is still an emerging area of research.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Santomasso, Bianca Denise — Sloan-Kettering Inst Can Research
- Study coordinator: Santomasso, Bianca Denise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.